Bradbury M, Savard MF, Stober C, Clemons L, et al. Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey. Breast Cancer Res Treat 2024 Apr 25. doi: 10.1007/s10549-024-07302.
PMID: 38664288